New! Sign up for our free email newsletter.
Science News
from research organizations

Surprising genetic variety in childhood brain cancer

Date:
July 19, 2017
Source:
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
Summary:
Scientists have identified new genetic alterations and mechanisms that lead to very aggressive types of childhood brain cancer. Their results will contribute to developing novel treatment approaches for previously incurable cancer cases and to targeting tumors more specifically.
Share:
FULL STORY

Medulloblastoma is a malignant tumor of the cerebellum. Medulloblastoma can occur at any age, but it most commonly affects children. Medulloblastomas are classified in four distinct molecular-biological subgroups that are characterized by widely varying disease courses and chances of cure. Tumors of groups 3 and 4 are particularly common in children. However, little is understood up to know about these two types. Therefore, treatment of cancers of this group is often very difficult. "Even if patients respond well to the treatment, their cancer is often being cured at high costs, because the therapy can have negative effects on the brain, the IQ and the children's further development," said Stefan Pfister from the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ), who is also the director of the Hopp Children's Tumor Center at the NCT Heidelberg (KiTZ) and pediatric oncologist at the Heidelberg University Hospital.

An international research team under the leadership of scientists from the German Cancer Research Center has now analyzed almost 500 medulloblastomas. They discovered that these brain cancers exhibit a much wider genetic variety than previously thought. In groups 3 and 4, in particular, more than half of the underlying genetic alterations had been completely unknown until now. "While we could previously explain only 30 percent of tumors in these groups on a molecular-biological basis, we have now reached 80 percent," emphasized Peter Lichter from the DKFZ.

This finding helps classify subgroups of medulloblastoma more precisely and treat them more individually in order to improve curative chances and reduce the risk for severe side effects. Lichter said that in some cases this could already be done using available agents. "In other subtypes we now understand the genetic causes for the first time so that we can search very specifically for new therapy approaches," said Lichter.

In addition, the scientists have identified alterations at the level of gene regulation as a typical mechanism for the occurrence of medulloblastoma. In a process called "enhancer hijacking," cancer genes frequently capture DNA sequences called "enhancers." Structural changes in the DNA cause an oncogene that should normally be inactive to move to a different position where it is activated by an enhancer, thus promoting the onset of cancer.


Story Source:

Materials provided by German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ). Note: Content may be edited for style and length.


Journal Reference:

  1. Paul A. Northcott, Ivo Buchhalter, A. Sorana Morrissy, Volker Hovestadt, Joachim Weischenfeldt, Tobias Ehrenberger, Susanne Gröbner, Maia Segura-Wang, Thomas Zichner, Vasilisa A. Rudneva, Hans-Jörg Warnatz, Nikos Sidiropoulos, Aaron H. Phillips, Steven Schumacher, Kortine Kleinheinz, Sebastian M. Waszak, Serap Erkek, David T. W. Jones, Barbara C. Worst, Marcel Kool, Marc Zapatka, Natalie Jäger, Lukas Chavez, Barbara Hutter, Matthias Bieg, Nagarajan Paramasivam, Michael Heinold, Zuguang Gu, Naveed Ishaque, Christina Jäger-Schmidt, Charles D. Imbusch, Alke Jugold, Daniel Hübschmann, Thomas Risch, Vyacheslav Amstislavskiy, Francisco German Rodriguez Gonzalez, Ursula D. Weber, Stephan Wolf, Giles W. Robinson, Xin Zhou, Gang Wu, David Finkelstein, Yanling Liu, Florence M. G. Cavalli, Betty Luu, Vijay Ramaswamy, Xiaochong Wu, Jan Koster, Marina Ryzhova, Yoon-Jae Cho, Scott L. Pomeroy, Christel Herold-Mende, Martin Schuhmann, Martin Ebinger, Linda M. Liau, Jaume Mora, Roger E. McLendon, Nada Jabado, Toshihiro Kumabe, Eric Chuah, Yussanne Ma, Richard A. Moore, Andrew J. Mungall, Karen L. Mungall, Nina Thiessen, Kane Tse, Tina Wong, Steven J. M. Jones, Olaf Witt, Till Milde, Andreas Von Deimling, David Capper, Andrey Korshunov, Marie-Laure Yaspo, Richard Kriwacki, Amar Gajjar, Jinghui Zhang, Rameen Beroukhim, Ernest Fraenkel, Jan O. Korbel, Benedikt Brors, Matthias Schlesner, Roland Eils, Marco A. Marra, Stefan M. Pfister, Michael D. Taylor, Peter Lichter. The whole-genome landscape of medulloblastoma subtypes. Nature, 2017; 547 (7663): 311 DOI: 10.1038/nature22973

Cite This Page:

German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ). "Surprising genetic variety in childhood brain cancer." ScienceDaily. ScienceDaily, 19 July 2017. <www.sciencedaily.com/releases/2017/07/170719132210.htm>.
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ). (2017, July 19). Surprising genetic variety in childhood brain cancer. ScienceDaily. Retrieved March 28, 2024 from www.sciencedaily.com/releases/2017/07/170719132210.htm
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ). "Surprising genetic variety in childhood brain cancer." ScienceDaily. www.sciencedaily.com/releases/2017/07/170719132210.htm (accessed March 28, 2024).

Explore More

from ScienceDaily

MORE COVERAGE

RELATED STORIES